Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soligenix, Inc. - Common Stock (NQ: SNGX )

2.260 -0.040 (-1.74%)
Streaming Delayed Price Updated: 10:05 AM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,627
Open 2.280
Bid (Size) 2.260 (2)
Ask (Size) 2.300 (12)
Prev. Close 2.300
Today's Range 2.260 - 2.280
52wk Range 1.830 - 14.92
Shares Outstanding 2,509,499
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’
Via Investor Brand Network
Soligenix Aims To Push The Boundaries In Treating Rare Diseases
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-23.13%
-23.13%
1 Month
-1.74%
-1.74%
3 Month
-31.72%
-31.72%
6 Month
-34.11%
-34.11%
1 Year
-79.99%
-79.99%

More News

Read More
Soligenix Aims To Push The Boundaries In Treating Rare Diseases
Via TheNewswire.com
Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease
Via NewMediaWire
Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease
Via TheNewswire.com
Soligenix Announces Participation at the Spartan Capital Investor Conference
Via TheNewswire.com
Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026
Via NewMediaWire
Exposures COVID-19
Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026
Via TheNewswire.com
Exposures COVID-19
Soligenix Targets Psoriasis With New Therapy
Via News Direct
EXCLUSIVE: Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
Via Benzinga
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
Via News Direct
EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer
Via Benzinga
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
Via News Direct
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Via ACCESSWIRE
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Soligenix Announces Participation at the Spartan Capital Investor Conference
Via NewMediaWire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.